HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clinical gene therapy for the treatment of RPE65-associated Leber congenital amaurosis.

AbstractINTRODUCTION:
The positive results of pioneering clinical trials using gene therapy as treatment for patients with Leber congenital amaurosis (LCA) have ushered in a new era of molecular retinal therapeutics for LCA, other blinding retinal disorders and gene therapy applications.
AREAS COVERED:
This review describes the role of retinal pigment epithelium-specific 65 kDa protein (RPE65) in the visual cycle and how RPE65 deficiency results in LCA; the extensive preclinical studies with recombinant adeno-associated virus (rAAV)-RPE65 gene vectors; and the human rAAV-RPE65 and related gene therapy clinical trials and studies. The literature search included a review of primary sources (e.g., journal articles) that reported study data results and key secondary sources such as meta-reviews available through PubMed, as well as reviews of clinical trial descriptions and results as reported in clinicaltrials.gov, conference publications and news releases.
EXPERT OPINION:
LCA-RPE65 gene therapy is an example of successful, innovative, translational research. Further research is needed regarding how retinal gene therapy can be improved.
AuthorsLinda Stein, Kamolika Roy, Lei Lei, Shalesh Kaushal
JournalExpert opinion on biological therapy (Expert Opin Biol Ther) Vol. 11 Issue 3 Pg. 429-39 (Mar 2011) ISSN: 1744-7682 [Electronic] England
PMID21299439 (Publication Type: Journal Article, Review)
Chemical References
  • Carrier Proteins
  • Eye Proteins
  • retinoid isomerohydrolase
  • cis-trans-Isomerases
Topics
  • Animals
  • Carrier Proteins (genetics, metabolism)
  • Dependovirus (genetics)
  • Evidence-Based Medicine
  • Eye Proteins (genetics, metabolism)
  • Gene Transfer Techniques
  • Genetic Therapy (adverse effects)
  • Genetic Vectors
  • Humans
  • Leber Congenital Amaurosis (genetics, metabolism, physiopathology, therapy)
  • Retina (metabolism, physiopathology)
  • Translational Research, Biomedical
  • Treatment Outcome
  • Vision, Ocular
  • cis-trans-Isomerases

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: